regenmedlab.bsky.social @regenmedlab.bsky.social · 12/09/2026Our editorial/commentary: "Fragile skin may benefit from decoration" sciencedirect.com/science/articl e/pii/S3117387X2600162X just appeared in the September issue of the Molecular Therapy Advances! 👍sciencedirect.com 000
regenmedlab.bsky.social @regenmedlab.bsky.social · 04/09/2026How do human large blood vessels respond to hypoxia? Paucity of evidence until large arteries & veins collected after severe lower extremity trauma reveal rapid, but transient intimal hyperplasia and adventitial angiogenesis from veins. @evborg.bsky.social @navbo.bsky.social rdcu.be/XyAQYUmiqQma 011
regenmedlab.bsky.social @regenmedlab.bsky.social · 03/09/2026We are in Halo! Our drug screening technology for homing and tissue penetrating macrocyclic peptides based on in vivo phage display & microdialysis (www.life-science-alliance.org/content/8/5/...) & macrocyclic homing peptides for targeted drug delivery are presented. www.halo.science/profile/tero...halo.scienceTero Järvinen's profileTero Järvinen is a Principal Investigator at Tampere University. Expertise in Biopharmaceutics, Cardiovascular, Molecular Biology. Explore collaboration opportunities on Halo Science. 011
Reposted by @regenmedlab.bsky.socialNature @nature.com · 21/07/2025These parents set up biotechnology companies, hoping to cure their children's illnesses go.nature.com/4o0hV92go.nature.comMeet the biotech-company founders driven by their child’s rare diseaseFor some parents, finding a cure for their child’s illness is the ultimate motivation to start a company. 0214
Reposted by @regenmedlab.bsky.socialTero Järvinen @terojarvinen.bsky.social · 10/09/2025Dr Afsaneh Ehsandoost come to my lab as a EDUFI-student. Happy to announce the publication of the chitosan scaffolds she created: a novel approach to mimicking native skin architecture doi.org/10.1088/1748... via @ioppublishing.bsky.socialdoi.orgBilayered chitosan scaffolds: a novel approach to mimicking native skin architecture - IOPscienceBilayered chitosan scaffolds: a novel approach to mimicking native skin architecture, Ehsandoost, Afsaneh, Järvinen, Tero A. H., Tamjid, Elnaz 021
Reposted by @regenmedlab.bsky.socialTero Järvinen @terojarvinen.bsky.social · 14/02/2026We have developed a new way of performing in vivo phage display screens by introducing microdialysis catheter into the in vivo screen to capture the macrocyclic homing and tissue penetrating peptides for efficient drug delivery www.life-science-alliance.org/content/8/5/... @lsajournal.org 141
Reposted by @regenmedlab.bsky.socialTero Järvinen @terojarvinen.bsky.social · 14/02/2026Macrocyclic vascular homing peptide CAR not only works as drug delivery vehicle, but as a drug by itself; CAR homes to skin wound, binds to syndecan 4, which activates cytohesin 2 to activate small GTPase Arf6 to accelerate skin wound closure. www.nature.com/articles/s41... @natcomms.nature.com 011
Reposted by @regenmedlab.bsky.socialTero Järvinen @terojarvinen.bsky.social · 30/04/2026In 2002, I watched hundreds of surgeons jump out of their seats to blast a speaker. @nejm.org Arthroscopic Partial Meniscectomy for Degenerative Tear — 10-Year Outcomes | New England Journal of Medicine www.nejm.org/doi/full/10....nejm.orgArthroscopic Partial Meniscectomy for Degenerative Tear — 10-Year Outcomes | NEJMIn this trial of arthroscopic partial meniscectomy for degenerative medial meniscal tear in adults, participant-reported and radiologic outcomes over 10 years of follow-up suggested no benefit and ... 111
Reposted by @regenmedlab.bsky.socialNEJM.org @nejm.org · 07/05/2026Three must-read articles that sparked major news coverage in April. 053
Reposted by @regenmedlab.bsky.socialNEJM.org @nejm.org · 03/05/2026In the FIDELITY trial of arthroscopic partial meniscectomy for degenerative medial meniscal tear in adults, participant-reported and radiologic outcomes over 10 years of follow-up suggested no benefit and possible harm from the procedure. Full trial results: nej.md/48Pkwww #Orthopedics 1144
Reposted by @regenmedlab.bsky.socialFICEBO @ficebo.bsky.social · 07/05/2026MedicalResearch.com now interview with Teppo Järvinen, Professor of Orthopaedics and Traumatology, University of Helsinki and HUS. You can find more information about the interview here: medicalresearch.com/nejm-arthros...medicalresearch.comNEJM: Arthroscopic Partial Meniscectomy Provided No Benefit Over Placebo Surgery and May Worsen Longterm OutcomesThis study contributes to the concept of medical reversal, where widely used treatments are shown to be ineffective or harmful when tested rigorously. 022
Reposted by @regenmedlab.bsky.socialTero Järvinen @terojarvinen.bsky.social · 18/06/2026Hot off the press! We demonstrate in Cancer Res that the αv integrin- and neuropilin-1 (NRP-1)-dual targeting iRGD peptide (in phase II clinical trials) reverses some of these tumor microenvironment features by inhibiting TGF-β activation in the tumor: aacrjournals.org/cancerres/ar... 011
regenmedlab.bsky.social @regenmedlab.bsky.social · 25/08/2026"Fragile skin may benefit from decoration" - our commentary (to Nyström-lab original article) addresses Decorin as a potential drug for the RDEB patients www.sciencedirect.com/science/arti... 000
